Kindred Biosciences, Inc.
NGF Antagonists for Medical Use

Last updated:

Abstract:

Provided are various embodiments relating to TrkA ECD polypeptides from companion animal species that bind to NGF. Such polypeptides can be used in methods to treat NGF-induced condition related to chronic pain and/or inflammatory pain in companion animals, such as canines, felines, and equines.

Status:
Application
Type:

Utility

Filling date:

20 Mar 2020

Issue date:

2 Jun 2022